Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Christophe Leclercq Added: 1 year ago
EHRA 2025 - Outcomes from cardiac resynchronization therapy (CRT) with MultiPoint pacing (MPP) to treat patients who are not responding to standard CRT show that MPP does not improve the conversion rate of non-responders to responders compared to standard CRT; however, a reduction in HF hospitalisation was seen in the group receiving MPP.Prof Christophe Leclercq (Centre Hospitalier Universitaire… View more
Author(s): Klaus Witte, Luca Santini, Alphons Vincent ,et al Start date: May 06, 2025
Join Dr Luca Santini (Rome, IT) and Prof Klaus Witte (Leeds, UK) for an engaging educational webinar exploring the critical importance of sensitivity and specificity in Insertable Cardiac Monitors (ICMs).Discover how reducing false positives impacts sensitivity, why balancing these factors is essential, and what real-world data reveals about achieving clinical accuracy. The session will also… View more
Author(s): Kevin Vernooy , Margarida Pujol Lopez Added: 1 year ago
Dr Kevin Vernooy (Maastricht University Medical Center, NL) is joined by Dr Margarida Pujol Lopez (Hospital Clinic of Barcelona, Barcelona, ES) to discuss ECG-based criteria to ensure electrical resynchronization with left bundle branch area pacing (LBBP).Dr Pujol Lopez presents the criteria for LBBP, as well as indications for cardiac resynchronization in this area. She discuses the LEVEL-AT… View more
Added: 1 year ago Source:  Arrhythmia Academy
AUTHOR: David RamseyLeading cardiovascular societies have unveiled an updated appropriate use criteria (AUC) document redefining clinical decision-making for cardiac implantable devices. The practice guideline entitled "ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy, and Pacing" was published online… View more
Author(s): John Hummel Added: 2 years ago
AHA 2023 — In this short interview, we are joined by Dr John Hummel (Ohio State University, US) to discuss the findings from the JEWEL-IDE (NCT05201495) study, which investigated the use of the Jewel patch-wearable cardioverter defibrillator (PWCD) system in participants who were at high risk for sudden cardiac arrest. This was a multicenter, prospective, single-arm trial, with 290 participants… View more